AbbVie Inc. Gross Profit 2011–2025
AbbVie Inc. reported $42.96B of gross profit for fiscal 2025. That was 8.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +41.2%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $42.96B | 70.2% | +8.9% |
| FY 2024 | $39.43B | 70.0% | +16.3% |
| FY 2023 | $33.90B | 62.4% | -16.6% |
| FY 2022 | $40.64B | 70.0% | +4.9% |
| FY 2021 | $38.75B | 69.0% | +27.4% |
| FY 2020 | $30.42B | 66.4% | +17.8% |
| FY 2019 | $25.83B | 77.6% | +3.2% |
| FY 2018 | $25.04B | 76.4% | +18.2% |
| FY 2017 | $21.17B | 75.0% | +6.9% |
| FY 2016 | $19.81B | 77.3% | +7.9% |
| FY 2015 | $18.36B | 80.3% | +18.2% |
| FY 2014 | $15.53B | 77.8% | +9.3% |
| FY 2013 | $14.21B | 75.6% | +2.4% |
| FY 2012 | $13.87B | 75.5% | +8.3% |
| FY 2011 | $12.80B | 73.4% | — |
Source: AbbVie Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABBV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
AbbVie Inc. reported $42.96B of gross profit for fiscal 2025. That was 8.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +41.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for AbbVie Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbVie Inc. — frequently asked questions
What is AbbVie Inc.'s gross profit?
AbbVie Inc. (ABBV) reported gross profit of $42.96B for fiscal year 2025, per its SEC filings.
How has AbbVie Inc.'s gross profit changed over time?
Between fiscal 2011 and 2025, ABBV's gross profit grew at roughly 9.0% per year (compound annual rate), from $12.80B to $42.96B.
Where does this data come from?
Figures are computed from AbbVie Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.